| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/03/2006 | EP1515955A4 Chemical process |
| 05/03/2006 | EP1513836B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 05/03/2006 | EP1505930A4 Drug-delivery endovascular stent and method for treating restenosis |
| 05/03/2006 | EP1490049B1 Citalopram for the treatment of elevated blood pressure |
| 05/03/2006 | EP1465870B1 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 05/03/2006 | EP1448986B1 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 05/03/2006 | EP1368006B1 Novel modified released formulation |
| 05/03/2006 | EP1355638B1 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 05/03/2006 | EP1353904B9 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/03/2006 | EP1336407B1 Composition containing an angiotensin ii receptor antagonist and a diuretic and its use for the treatment of hypertension |
| 05/03/2006 | EP1311486B1 Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same |
| 05/03/2006 | EP1253935B1 Use of placenta growth factor for preventing or treating ischemic diseases or stroke |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1232748B1 Use of substituted nitrobenzene derivatives for the treatment of diseases caused by bacteria, fungi and viruses |
| 05/03/2006 | EP1210065B1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 05/03/2006 | EP1188755B1 Acylhydrazine derivatives, process for preparing the same and use thereof |
| 05/03/2006 | EP1126863B1 Vascular endothelial growth factor-like protein from orf virus nz10 binds and activates mammalian vegf receptor-2 |
| 05/03/2006 | EP1099692B1 N,n-substituted cyclic amine derivatives |
| 05/03/2006 | EP0934326B1 Substituted aminoalkane phosphonic acids |
| 05/03/2006 | EP0927217B1 Angiogenic inhibitory compounds |
| 05/03/2006 | EP0810884B1 Treatment of vascular restenosis with inhaled nitric oxide |
| 05/03/2006 | EP0793500B1 Pharmaceutical compositions comprising nitric oxide-releasing polysaccharides |
| 05/03/2006 | CN1768138A Method for producing recombinant proteins in micro-organisms |
| 05/03/2006 | CN1768071A Lipid-regulating agent and use thereof |
| 05/03/2006 | CN1767870A Otorhinological delivery device |
| 05/03/2006 | CN1767844A Rosmarinic acid composition |
| 05/03/2006 | CN1765416A Health caring plaster |
| 05/03/2006 | CN1765415A Piles ointment and its preparation method |
| 05/03/2006 | CN1765408A Medicine for preventing and treating cardiovascular and cerebrovasulcar disease and preparation method thereof |
| 05/03/2006 | CN1765407A Blood fat decreasing pill |
| 05/03/2006 | CN1765405A Chinese medicine for treating cardiovascular and cerebrovasular disease and apoplexy hemiparalysis |
| 05/03/2006 | CN1765390A Chinese medicine for treating pulmonary heart disease |
| 05/03/2006 | CN1765389A Gall relieving pill |
| 05/03/2006 | CN1765378A Blood circulation activating pill |
| 05/03/2006 | CN1765363A Naftopidil soft capsule and its preparation method |
| 05/03/2006 | CN1765362A Composition containing amlodipine and angiotensin II receptor inhibitor |
| 05/03/2006 | CN1765359A Pharmaceutical formulation for treating arrhythmia |
| 05/03/2006 | CN1765357A Application of carthamin yellow B in preparation of medicine for treating cardiovascular and cerebrovasular disease |
| 05/03/2006 | CN1765355A Propafenone sustained release formulation and its preparation method |
| 05/03/2006 | CN1254475C 5-methoxy-8-aryl-[1,2,4]triazolo[1,5-a]pyridine derivatives as adenosine receptor antagonists |
| 05/03/2006 | CN1254274C Recombinant hirudin oral enteric soluble slowly-releasing preparation |
| 05/03/2006 | CN1254265C Apoplexy treating medicine preparation |
| 05/03/2006 | CN1254259C Chinese medicinal preparations for cardiac and encephalic blood vessel diseases and productions thereof |
| 05/03/2006 | CN1254255C Oral liquor for curing cerebral hemorrhage and its preparation method |
| 05/03/2006 | CN1254252C Medicine for treating ischemic angiocardiopathy and cerebrovascular disease and its preparation method |
| 05/03/2006 | CN1254243C Pharmaceutical compositions comprising chelidonine or derivatives thereof |
| 05/02/2006 | USRE39088 Amide compounds and use of the same |
| 05/02/2006 | US7038048 Compositions for treatment of cell proliferation disorders |
| 05/02/2006 | US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering |
| 05/02/2006 | US7037929 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/02/2006 | US7037928 Compositions of N-(methylethylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 05/02/2006 | US7037926 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 05/02/2006 | US7037920 Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists |
| 05/02/2006 | US7037918 Antidiabetic agents, cardiovascular disorders, Alzheimer's disease, nervous system disorders |
| 05/02/2006 | US7037911 For thromboembolic disorder from unstable angina, acute coronary syndrome, myocardial infarction, ischemia, stroke, atherosclerosis |
| 05/02/2006 | US7037907 Prodrug of an estradiol conjugated to a glucuronide sugar; 6-oxo-2-methoxyestradiol; 3-acetyl-6-oxo-2-methoxyestradiol; and 2-methoxyestradiol-6-hydrazone; angiogenesis inhibitor; antiinflammatory for asthma or rheumatoid arthritis |
| 05/02/2006 | US7037896 HIV inhibiting peptide (VIRIP) and amidated, acetylated, sulfated, polyethylene glycol modified, phosphorylated and/or glycosylated derivatives |
| 05/02/2006 | US7037709 Comprises nucleotide sequences coding microsomal enzymes for detoxification of xenobiotic compounds in liver; drug screening; gene therapy |
| 05/02/2006 | US7037701 Genetic engineering; detection moderators of kinase peptidespeptides |
| 05/02/2006 | US7037666 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction |
| 05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |
| 05/02/2006 | US7037533 Functional agent for decomposing nicotine and method of preparing the same |
| 05/02/2006 | US7037332 Medical device with coating that promotes endothelial cell adherence |
| 05/02/2006 | CA2334012C 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 05/02/2006 | CA2174544C Method for using pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenyl-amino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines as adrenergic agents |
| 05/02/2006 | CA2173974C Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 05/02/2006 | CA2061836C Nmda antagonists |
| 04/27/2006 | WO2006045049A1 Angiopoietin-2 specific binding agents |
| 04/27/2006 | WO2006045010A2 Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases |
| 04/27/2006 | WO2006044961A1 Ppar-gamma modulatores |
| 04/27/2006 | WO2006044856A2 Use of a2a adenosine receptor agonists |
| 04/27/2006 | WO2006044648A1 Process for preparing telmisartan |
| 04/27/2006 | WO2006044602A2 Diphenyl substituted alkanes as flap inhiibitors |
| 04/27/2006 | WO2006044415A2 Carboxylic acid peri - substituted bicyclics for occlusive artery disease |
| 04/27/2006 | WO2006044405A1 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | WO2006044000A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | WO2006043728A1 Method of screening insulin resistance-improving agent |
| 04/27/2006 | WO2006043722A1 Chimeric (double) decoy |
| 04/27/2006 | WO2006043671A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |
| 04/27/2006 | WO2006043594A1 1,5-diheterocycle-1h-triazole derivative |
| 04/27/2006 | WO2006043515A1 Pyrimidine-5-carboxylic acid derivative |
| 04/27/2006 | WO2006043510A1 Ester derivative and pharmaceutical use thereof |
| 04/27/2006 | WO2006042638A1 3,6-substituted 5-arylamino-1h-pyidine-2-one derivatives and related compounds as poly(adp-ribose)polymerase (parp) inhibitors in the treatment of tissue damage or disease caused by necrosis or apoptosis |
| 04/27/2006 | WO2006042454A1 Puerarin derivatives and their medical uses |
| 04/27/2006 | WO2006005581A3 A composition comprising a pharmacologically active agent coupled to a target cell specific component, and a saponin |
| 04/27/2006 | WO2006002453A3 Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface |
| 04/27/2006 | WO2005099755A3 Methods of treating autoimmune and inflammatory diseases |
| 04/27/2006 | WO2005051404A8 Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases |
| 04/27/2006 | US20060089404 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 04/27/2006 | US20060089394 {[2-Methyl-4-({[4'-(trifluoromethyl)-3-biphenylyl]methyl}thio)phenyl]oxy}acetic acid; adipogenic signalling cascade and lipid homeostasis; increase High Density Lipoproteins; hypotensive agent; Syndrome X, obesity, insulin resistance, cardiovascular disorder |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089362 N-(2- piperazinophenyl) methyl 3-(3-chlorophenyl)-pyrazolo-[1,5-a]-pyrimidine-6-amide; treats circulatory diseases such as diseases due to inflammation, circulatory disorders, enhanced proliferation activities, and the like, i.e., hypertension, diabetes, diabetic complications, arteriosclerosis |
| 04/27/2006 | US20060089353 Indole derivative compounds and drugs containing the compounds as the active ingredient |
| 04/27/2006 | US20060089345 Indole derivatives, method for preparating same and pharmaceutical compositions containing same |
| 04/27/2006 | US20060089344 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; preventing or treating a pathology in which endogenous cannabinoids and/or any other substrate metabolized by the enzyme FA; analgesics |
| 04/27/2006 | US20060089336 4-Dedimethylamino tetracycline compounds |
| 04/27/2006 | US20060089334 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 04/27/2006 | US20060089312 Protease inhibitors |
| 04/27/2006 | US20060089299 Selective treatment of endothelial somatostatin receptors |
| 04/27/2006 | US20060088915 A G protein-coupled receptor protein for the treatment of digestive diseases |